Novel Cytotoxic Phenanthro-triazine-3-thiol Derivatives as Potential DNA Intercalators and Bcl-2 Inhibitors

AuthorMehdi Khoshneviszadehen
AuthorOmidreza Firuzien
AuthorMalihe Aminsafaeeen
AuthorMasoud Kashefizadehen
AuthorSara Ranjbaren
AuthorZahra Rezaeien
AuthorHossein Sadeghpouren
AuthorFarshid Zargarien
AuthorRamin Mirien
AuthorNajmeh Edrakien
Issued Date2021-07-31en
AbstractNovel phenanthro-triazine-3-thiol derivatives were designed as potential DNA intercalators and Bcl-2 inhibitors. After being synthesized, the compounds were evaluated for their cytotoxic activity against MOLT-4 (human acute lymphoblastic leukemia) and MCF-7 (human breast adenocarcinoma) cells by MTT assay. P1 (bearing hydrogen substitution) was the most potent derivative against MOLT-4 with an IC50 value of 7.1 ± 1.1 μM, whereas P11 (bearing phenyl substitution) demonstrated considerable cytotoxicity against MCF-7 with an IC50 value of 15.4 ± 2.9 μM. Compounds P7, P8, P14 and P15 exhibited moderate cytotoxic effects. Furthermore, to confirm the potential DNA intercalation and Bcl-2 inhibitory activities of phenanthro-triazine scaffolds, molecular docking analysis was performed. Molecular docking studies indicated that these compounds not only bind to DNA by intercalation mainly through stacking interactions but also are well accommodated in the active site of Bcl-2. Therefore, P1 and P11 having phenanthro-triazine-3-thiol scaffold could be presented as cytotoxic agents with dual DNA intercalation and Bcl-2 inhibitory activities.en
DOIhttps://doi.org/10.22037/ijpr.2020.113902.14553en
KeywordTriazineen
KeywordPhenanthreneen
KeywordCanceren
KeywordAntiproliferative effecten
KeywordMolecular dockingen
PublisherBrieflandsen
TitleNovel Cytotoxic Phenanthro-triazine-3-thiol Derivatives as Potential DNA Intercalators and Bcl-2 Inhibitorsen
TypeOriginal Articleen

Files